ARTICLE
|
doi:10.20944/preprints201809.0540.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Modified FOLFIRINOX; Severe neutropenia; Overall survival; Overall response rate; Time to treatment failure; Advanced pancreatic cancer
Online: 27 September 2018 (10:12:08 CEST)